COVID VACCINE INVESTING. Up to date information about the smaller bio-pharmaceutical companies developing a COVID vaccine. This blog features a COVID INVESTOR INDEX which keeps track of the relative performance of 28 key COVID VACCINE companies.
Monday, 31 January 2022
Explosion upwards. One of biggest days of all time with an 8.6% overall gain. Fully 10 stocks picked up more than 10%
Saturday, 29 January 2022
Overall return slips further to 61%. BioNTech moves into 3rd
Friday, 28 January 2022
Huge Bounce Back day - up 4.8% overall
Thursday, 27 January 2022
Total Wash Out. One of the worst days ever. Average loss of 5.5% on average. Sorrento and Tonix falls more than 10%
Friday, 21 January 2022
Dance the Limbo! CureVac down 14% - 4.5% sell off
Thursday, 20 January 2022
Pain continues - 2.7% losses on average overall
Wednesday, 19 January 2022
Another 2.4% loss overall. OncoSec hit with a double digit loss
Tuesday, 18 January 2022
Irrational Overwrought Hatred of Covid Vaccine Stocks Continue - 7.2% Loss on average
Saturday, 15 January 2022
Total Return just 101%. Every stock in top ten loses ground.
Friday, 14 January 2022
Finally some strength in the mid-sized group with GeoVax and CureVac whacked
Thursday, 13 January 2022
Heavy blow for Covid Vaccine Stocks with a loss of 3.5%. Novavax tumbles, Onco Sec bounces.
Monday, 10 January 2022
Big Boys had a strong day... Moderna and BioNTech up 9%
Saturday, 8 January 2022
Covid Stocks limp downwards to lowest total return in almost two years. Moderna hit hardest.
Covid Vaccine stocks are down to just 113% return. This a low ebb - lowest since the very early days of the pandemic in the spring of 2021.
The big three also got hammered this week.
On December 18, 2021, Novavax had a return of 1258%. It now sits at 701% for a drop of 557%.
Moderna slipped 152% and BioNTech slipped 130 points.
Sorrento was the only gainer in the TOP TEN which picked up 17% on the week
Friday, 7 January 2022
Stocks ease lower - just under 1% loss on average
Thursday, 6 January 2022
Flat Day - 16 losers and 11 winners
Wednesday, 5 January 2022
ROYAL FLUSH.....right down the toilet
Tuesday, 4 January 2022
HELL DAY! Gritstone and NanoViricides wrecked
Saturday, 1 January 2022
PDS Bio makes biggest move in 2021. OncoSec the worst
PDS Bio performed the best of all COVID VACCINE STOCKS, improving its overall return by 279% during 2021. The stock jumped from $2.14 to $8.10.
OncoSec performed the worst, falling off a cliff, from $6.45 to $.96.
Interestingly, only 10 stocks improved their return during the teeth of the Covid Pandemic over the course of 2021.
BioNTech and Dynavax improved their total return by 216% during the year.